Enveric Biosciences, Inc. (NASDAQ:ENVB) Financings

Enveric Biosciences, Inc.

Financings

RaiseDate
Private placement of shares of common stock (or pre-funded warrants) with Series I and short-term Series J warrants
Closed: US$5M raised · US$2.25 a share · Warrants at US$2 · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Product development, working capital and general corporate purposes
Apr 17, 2026
Registered direct offering of shares of common stock with unregistered series G and series H warrants
Closed: US$1.5M raised · US$4.41 a share · Warrants at US$4.16 · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Product development, working capital and general corporate purposes
Jan 28, 2026
Warrant exercise of outstanding warrants exercised for common stock
Closed: US$3.1M raised · US$7.05 a share · Warrants at US$7.05 · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Product development, working capital and general corporate purposes
Dec 12, 2025
Warrant exercise of series A and series B warrants exercised for common stock
Closed: US$2.2M raised · US$0.915 a share · Warrants at US$0.915 · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Product development, working capital and general corporate purposes
Sep 18, 2025
Public offering of common stock (or common stock equivalents) with Series A and Series B warrants
Closed: US$5M raised · US$3 a share · Warrants at US$3 · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Product development, working capital and general corporate purposes
Feb 3, 2025

Read by 6ix AI from the company's releases